Michael A. Kaliner, MD, Professor of Medicine, George Washington University School of Medicine, Washington, DC; Section Chief, Allergy, Washington Hospital Center, Washington, DC Intranasal ...

Fluticasone furoate 27.5 µg/spray; alcohol-free. Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. The exact mechanism by which this ...

Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...

When a corticosteroid preparation is given to a child, the prescribing healthcare provider always should consider the risk/benefit ratio of a particular medication. Known side effects of systemic ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Wilmington, DE – August 26, 2004 – AstraZeneca announced today that the U.S. Food and Drug Administration (FDA) has approved revised labeling for its anti-inflammatory corticosteroid nasal spray ...

Please provide your email address to receive an email when new articles are posted on . Patients received prednisolone or ebastine daily for 7 days during tree pollen season. Daily symptom scores and ...

Allergic rhinitis, chronic inflammation of the lining membrane of the nose, is triggered by allergens such as trees, grasses, weeds, dust mites and animal dander. The interaction between allergens, ...

Ottawa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The global intranasal corticosteroids market size was valued at USD 7.22 billion in 2024 and is predicted to hit around USD 11.57 billion by 2034, rising at a ...

LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global allergy rhinitis drugs market is expected to grow at a CAGR of more than 3% during the forecast period.